UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

Transplantation, 2013-08, Vol.96 (4), p.333-360

2013

Volltextzugriff (PDF)

New Developments in the Management of Cytomegalovirus Infection After Transplantation

Drugs (New York, N.Y.), 2018-07, Vol.78 (11), p.1085-1103

2018

Volltextzugriff (PDF)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation, 2010-04, Vol.89 (7), p.779-795

2010

Volltextzugriff (PDF)

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Transplant infectious disease, 2019-12, Vol.21 (6), p.e13187-n/a

2019

Volltextzugriff (PDF)

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.290-299

2012

Volltextzugriff (PDF)

The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Transplantation, 2023-08, Vol.107 (8), p.1671-1672

Kotton, Camille Nelson

2023

Volltextzugriff (PDF)

A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial

Transplantation, 2024-01, Vol.108 (1), p.261

2024

Volltextzugriff (PDF)

Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients

Annual review of medicine, 2023-01, Vol.74 (1), p.89-105

2023

Volltextzugriff (PDF)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Transplantation, 2023-08, Vol.107 (8), p.1846-1853

2023

Volltextzugriff (PDF)

Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial

Transplantation, 2023-08, Vol.107 (8), p.1835-1845

2023

Volltextzugriff (PDF)

Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir

Transplantation, 2016-04, Vol.100 (4), p.862-870

2016

Volltextzugriff (PDF)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV

Transplantation, 2016-03, Vol.100 Suppl 3 (Supplement 3S), p.S11-S18

Carbone, Javier

2016

Volltextzugriff (PDF)

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

Drugs (New York, N.Y.), 2010-05, Vol.70 (8), p.965-981

2010

Volltextzugriff (PDF)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients

Transplantation, 2016-03, Vol.100 Suppl 3 (Supplement 3S), p.S5-S10

2016

Volltextzugriff (PDF)

The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis

Transplantation, 2022-06, Vol.106 (6), p.1227-1232

2022

Volltextzugriff (PDF)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

Transplantation, 2020-07, Vol.104 (7), p.1508-1518

2020

Volltextzugriff (PDF)

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

European journal of haematology, 2024-02, Vol.112 (2), p.301-309

2024

Volltextzugriff (PDF)

Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy

Clinical transplantation, 2024-09, Vol.38 (9), p.e15419-n/a

2024

Volltextzugriff (PDF)

Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?

Transplant infectious disease, 2024-08, Vol.26 (4), p.e14292-n/a

2024

Volltextzugriff (PDF)

Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation

Clinical transplantation, 2023-10, Vol.37 (10), p.e15065

2023

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2011-04, Vol.11 (4), p.284-292

2011

Volltextzugriff (PDF)

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance

Clinical transplantation, 2024-09, Vol.38 (9), p.e15453-n/a

2024

Volltextzugriff (PDF)

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

Transplantation, 2020-10, Vol.104 (10), p.2139-2147

2020

Volltextzugriff (PDF)

Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation

Transplant infectious disease, 2022-12, Vol.24 (6), p.e13904-n/a

2022

Volltextzugriff (PDF)

1 – 25 von 587

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Zeitschrift / SerieTransplantation Proceedings

ThemaTransplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(564)
Mit Volltextzugriff
(332)

Publikationsform

Artikel
(587)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(571)
Life Sciences & Biomedicine
(569)
Science & Technology
(569)
Cytomegalovirus Infections - Prevention & Control
(462)
Immunology
(357)
Cytomegalovirus
(345)
Female
(332)
Male
(329)
Surgery
(305)
Adult
(280)
Middle Aged
(280)
Antiviral Agents - Therapeutic Use
(259)
Biological And Medical Sciences
(225)
Medical Sciences
(223)
Infectious Diseases
(182)
Retrospective Studies
(174)
Ganciclovir - Therapeutic Use
(162)
Risk Factors
(150)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(143)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

New Developments in the Management of Cytomegalovirus Infection After Transplantation

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial

Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial

Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients

The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy

Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?

Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation

Aktive Filter

Suchergebnisse filtern